Logo

Oncocyte: Gisela Paulsen, Anish John

Aug 11, 2022

Oncocyte has appointed Gisela Paulsen as president and Anish John as CFO.

Paulsen has been COO of the company since October and will also continue in that position, Oncocyte said in a Form 8-K filed with the US Securities and Exchange Commission. Prior to joining the firm, she was GM of precision oncology at Exact Sciences, and before that she held various management positions at Roche and its subsidiary Genentech, including SVP and global head of product development and clinical operations at both firms from January 2018 to April 2020.

John was previously SVP of finance at Oncocyte and had been its interim CFO since June. Prior to that, he was VP of operations and finance for the transplant business unit at Oncocyte. He was also senior director of financial planning and analysis for Foundation Medicine, now part of Roche. Before that, John was at PerkinElmer where he held various management roles.

Breaking News
The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.